Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.
Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, van Eden W, van der Zee R, Biedermann T, Prinz J, Mack M, Mrowietz U, Christophers E, Schlöndorff D, Plewig G, Sander CA, Röcken M.
Ghoreschi K, et al.
Nat Med. 2003 Jan;9(1):40-6. doi: 10.1038/nm804. Epub 2002 Dec 2.
Nat Med. 2003.
PMID: 12461524